SU1834006A1 - Противоопухолевое средство - Google Patents

Противоопухолевое средство

Info

Publication number
SU1834006A1
SU1834006A1 SU4497231/14A SU4497231A SU1834006A1 SU 1834006 A1 SU1834006 A1 SU 1834006A1 SU 4497231/14 A SU4497231/14 A SU 4497231/14A SU 4497231 A SU4497231 A SU 4497231A SU 1834006 A1 SU1834006 A1 SU 1834006A1
Authority
SU
USSR - Soviet Union
Prior art keywords
molecular mass
homocitrulline
nitroso
chloroethyl
antitumor agent
Prior art date
Application number
SU4497231/14A
Other languages
English (en)
Inventor
Н.М. Перетолчина
Л.Б. Радина
Л.Б. Горбачева
М.Я. Шашкина
Т.В. Мкртчян
И.А. Соколова
М.А. Краснова
З.П. Софьина
А.К. Белоусова
Е.Б. Некрасова
А.Б. Сыркин
Т.С. Шулепова
А.С. Сингин
А.А. Беляев
В.П. Краснов
Г.Л. Левит
А.И. Тарасов
Н.В. Ключанская
Н.И. Переводчикова
И.Н. Петухова
Н.И. Зимакова
Original Assignee
Всесоюзный онкологический научный центр АМН СССР
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Всесоюзный онкологический научный центр АМН СССР filed Critical Всесоюзный онкологический научный центр АМН СССР
Priority to SU4497231/14A priority Critical patent/SU1834006A1/ru
Application granted granted Critical
Publication of SU1834006A1 publication Critical patent/SU1834006A1/ru

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Область применения: изобретение относится к медицине, а именно онкологии. Цель: повышение активности средства и снижение побочных эффектов. Сущность изобретения: состав содержит (в мас.%): 9-(2-хлорэтил)-7-нитрозо-L-гомоцитруллин) 0,6-0,95; 9-(2-хлорэтил)-9-нитрозо-L-гомоцитруллин) 0,05-0,4; декстран (м. м. 40000) или полиглюкин (м.м. 60000) или поливинилпирролидон (м. м. 12600) 0,5-2,0; лимонную кислоту или сорбиновую кислоту 0,025-0,1; воду для инъекций или 5%-ный раствор глюкозы или изотонический раствор натрия хлорида до 100. 14 табл., 4 ил.
SU4497231/14A 1988-10-24 1988-10-24 Противоопухолевое средство SU1834006A1 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU4497231/14A SU1834006A1 (ru) 1988-10-24 1988-10-24 Противоопухолевое средство

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU4497231/14A SU1834006A1 (ru) 1988-10-24 1988-10-24 Противоопухолевое средство

Publications (1)

Publication Number Publication Date
SU1834006A1 true SU1834006A1 (ru) 1996-10-27

Family

ID=60537990

Family Applications (1)

Application Number Title Priority Date Filing Date
SU4497231/14A SU1834006A1 (ru) 1988-10-24 1988-10-24 Противоопухолевое средство

Country Status (1)

Country Link
SU (1) SU1834006A1 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012095607A1 (fr) * 2011-01-14 2012-07-19 Universite Paris Descartes Action preventive de la citrulline sur le developpement spontane des tumeurs

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012095607A1 (fr) * 2011-01-14 2012-07-19 Universite Paris Descartes Action preventive de la citrulline sur le developpement spontane des tumeurs

Similar Documents

Publication Publication Date Title
Segerbäck Alkylation of DNA and hemoglobin in the mouse following exposure to ethene and ethene oxide
ATE88352T1 (de) Humanes relaxinpraeparat.
CO4700482A1 (es) Formulaciones de un analogo monomero de insulina
KR900015737A (ko) 배합물
DE3579751D1 (de) Gluco-oligosaccharid-gemisch und verfahren zu seiner herstellung.
EP0322182A3 (en) Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
IT1137640B (it) Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
IL140848A (en) Pharmaceutical compositions containing phenylacetylglutamine, phenylacetylisoglutamine and/or phenylacetate
GB1212055A (en) Stable orally active heparinoid complexes
KR0143084B1 (ko) 항-hiv 작용을 가진 헤파린단편 및 분획
KR890014480A (ko) 2-피리딜아세트산 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
SU1834006A1 (ru) Противоопухолевое средство
ES8308215A1 (es) "procedimiento para preparar una composicion de conservacion de lentes de contacto blandas".
GB1506664A (en) Antiviral compositions
Kawaguchi et al. Occurrence of Galβ (1å3) GalNAc-SerThr in the linkage region of polygalactosamine containing fungal glycoprotein from Cordyceps ophioglossoides
ES468938A1 (es) Metodo de preparacion de auranofin.
EP0340933A3 (en) Heparin-containing formulations
KR870000930A (ko) 글리코사미노글리칸에 의한 항-혈전제의 제조방법
SE8206728D0 (sv) Lekemedelspreparat
JPS56138112A (en) Suppository containing ascorbic acid or sodium ascorbate
EP0127389A3 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
AU670697B2 (en) Sulfate of N-acetylneuraminic acid homopolymer, process for producing the same, anti-HIV drug containing said sulfate, method of treating AIDS with said sulfate, use of said sulfate for treating AIDS, and use of said sulfate for producing the drug
ES456196A1 (es) Un metodo para la preparacion de heparina de elevada activi-dad especifica.
KR920700685A (ko) K1K2P pro의 안정화
Donovick et al. Chemotherapy of Tuberculosis: IV. Studies with Sulfones in the Mouse

Legal Events

Date Code Title Description
REG Reference to a code of a succession state

Ref country code: RU

Ref legal event code: QB4A

Effective date: 20070209